局部给药的牛中pyrifos的药理动力学和区域皮肤分布
Karen Larsen1, Paula Ichinose2, Victoria Miró2
1Departamento de Ciencias Biológicas, Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires (UNCPBA), Centro de Investigación Veterinaria de Tandil (CIVETAN), UNCPBA-CICPBA-CONICET, Argentina.
Veterinary parasitology, regional studies and reports
|December 7, 2025
概括
在牛中对pyrifos (CPF) 的这项研究显示,局部应用后系统吸收低,没有显著的胆酶抑制. 皮肤分布不均,与后耳区域相比,在背部和部的度更高.
科学领域:
- 兽医药理学 兽医药理学
- 毒理学 毒理学 毒理学
- 皮肤病学 皮肤病学
背景情况:
- хлорпирифос (CPF) 正在重新用于南美洲牛的外寄生虫控制.
- 了解其在牛中的药理动力学和毒动力学对于安全有效的使用至关重要.
研究的目的:
- 在牛中局部使用后,对CPF的血可用性和皮肤区域分布进行表征.
- 评估CPF及其代谢物CPF-oxon对胆酶活性的体外和体内影响.
主要方法:
- CPF是局部给的,在21天内采集了血和皮肤样本.
- 使用HPLC测量药物度.
- 进行了体外和体外胆酶抑制试验.
主要成果:
- 在CPF中,全身暴露低,血度在0.06~0.15μg/mL之间.
- 皮肤与血AUC比率因地区 (285-2054) 有显著差异,在背线度最高.
- 没有观察到显著的体内胆酶抑制;没有检测到CPF-oxon.
结论:
- 局部CPF在健康牛中表现出低系统吸收和最小的体内胆酶抑制.
- 皮肤分布不均表明有针对性分娩的潜力,但需要进一步调查.
- 局限性包括缺乏寄生动物牛的数据和对代谢物更敏感的分析方法的需求.
更多相关视频
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.5K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Distribution
244
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
244
Nonlinear Pharmacokinetics: Overview
1.0K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.0K
Local Anesthetics: Pharmacokinetics
1.1K
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
1.1K
Tissue-Drug Binding: Localization of Drugs and its Significance
381
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
381
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
231
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
231


